A novel anti-fibrotic agent
Date Posted: 19/09/2018
Activated hepatic stellate cells (HSCs) play a major role in the development of liver fibrosis and their activation is the target of many anti-fibrotic therapies. However, these approaches have remained ineffective mainly due to an incomplete understanding of the molecular mechanisms underlying HSC activation and the lack of target specificity of candidate drugs.
For more information, please click here